awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38114062-3E6A0B66-C62E-4D33-B14C-7235D9BD1401
Q38114062-3E6A0B66-C62E-4D33-B14C-7235D9BD1401
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38114062-3E6A0B66-C62E-4D33-B14C-7235D9BD1401
Targeted therapies in the treatment of advanced hepatocellular carcinoma
P2860
Q38114062-3E6A0B66-C62E-4D33-B14C-7235D9BD1401
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38114062-3E6A0B66-C62E-4D33-B14C-7235D9BD1401
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e4014f2827002ccb6c618714cefdc4cd36a7d7fc
P2860
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.